Alkahest Overview
- Founded
-
2014

- Status
-
Acquired/Merged
- Employees
-
71

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$146M
- Investors
-
1
Alkahest General Information
Description
Owner and operator of a biotechnology company intended to enrich the health and vitality of humankind through transformative therapies that counterbalance the aging process. The company's therapies are used to augment the factors in the blood plasma in order to reverse detrimental effects of aging in both normal aging and disease models in animals, enabling doctors to improve vitality and find treatment for diseases of aging.
Contact Information
Website
www.alkahest.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- 125 Shoreway Road
- Suite D
- San Carlos, CA 94070
- United States
+1 (650) 000-0000
Alkahest Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 15-Dec-2020 | $146M | 000.00 | 00000 | Completed | Clinical Trials - Phase 2 |
3. Grant | 12-Feb-2018 | 000.00 | Completed | Clinical Trials - Phase 2 | ||
2. Corporate | 23-Nov-2015 | $35.9M | $39.4M | 000.00 | Completed | Clinical Trials - Phase 2 |
1. Early Stage VC (Series A) | 10-Jul-2014 | $3.5M | $3.5M | Completed | Clinical Trials - Phase 2 |
Alkahest Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Owner and operator of a biotechnology company intended to enrich the health and vitality of humankind through transforma
Drug Discovery
San Carlos, CA
71
As of 2020
000.00
0000
0000-00-00
000000&0
000.00
Alkahest Competitors (45)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Tranquis | Venture Capital-Backed | Redwood City, CA | 00 | 0000 | 00000000000 | 0000 |
00000000 000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
0000000 | Venture Capital-Backed | Emeryville, CA | 00 | 00000 | 00000000000 | 00000 |
0000000000 | Formerly VC-backed | Cambridge, MA | 00 | 0000 | 000000&0 | 0000 |
0000000000 | Venture Capital-Backed | Lausanne, Switzerland | 00 | 000.00 | 0000000000 | 000.00 |
Alkahest Patents
Alkahest Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210301013-A1 | Methods and compositions for treating aging-associated impairments with trefoil factor family member 2 modulators | Pending | 26-Nov-2019 | 00000000000 | |
US-20210171626-A1 | Methods and compositions for treating aging-associated impairments with trefoil factor family member 2 modulators | Pending | 26-Nov-2019 | 000000000 | |
AU-2020393882-A1 | Methods and compositions for treating aging-associated impairments with trefoil factor family member 2 modulators | Pending | 26-Nov-2019 | 000000000 | |
CA-3156923-A1 | Methods and compositions for treating aging-associated impairments with trefoil factor family member 2 modulators | Pending | 26-Nov-2019 | 000000000 | |
AU-2020388572-A1 | Blood plasma fractions for use in liver regeneration | Pending | 20-Nov-2019 | A61P1/16 |
Alkahest Executive Team (9)
Alkahest Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
David Bell | Grifols | Board Member | 000 0000 |
Karoly Nikolich Ph.D | Self | Co-Founder, Chief Executive Officer & Chairman | 000 0000 |
Tony Wyss-Coray Ph.D | Alkahest | Co-Founder, Board Member & Chairman of Scientific Advisory Board | 000 0000 |
Alkahest Signals
Alkahest Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Michael J. Fox Foundation | Limited Partner | 000 0000 | 000000 0 | ||
Pivotal Life Sciences | Venture Capital | Minority | 000 0000 | 000000 0 |